KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Shares Outstanding (2016 - 2025)

Abbott Laboratories' Shares Outstanding history spans 7 years, with the latest figure at $1.7 billion for Q4 2015.

  • For Q4 2015, Shares Outstanding changed 0.42% year-over-year to $1.7 billion; the TTM value through Dec 2015 reached $1.7 billion, changed 0.42%, while the annual FY2015 figure was $1.7 billion, 0.42% changed from the prior year.
  • Shares Outstanding for Q4 2015 was $1.7 billion at Abbott Laboratories, roughly flat from $1.7 billion in the prior quarter.
  • Across five years, Shares Outstanding topped out at $1.7 billion in Q4 2015 and bottomed at $1.6 billion in Q4 2011.
  • The 5-year median for Shares Outstanding is $1.7 billion (2013), against an average of $1.7 billion.
  • The largest annual shift saw Shares Outstanding decreased 5.8% in 2011 before it skyrocketed 2346.92% in 2012.
  • A 5-year view of Shares Outstanding shows it stood at $68.5 million in 2011, then surged by 2346.92% to $1.7 billion in 2012, then increased by 0.59% to $1.7 billion in 2013, then rose by 0.54% to $1.7 billion in 2014, then rose by 0.42% to $1.7 billion in 2015.
  • Per Business Quant, the three most recent readings for ABT's Shares Outstanding are $1.7 billion (Q4 2015), $1.7 billion (Q4 2014), and $1.7 billion (Q4 2013).